Argus raised Integra Lifesciences' price objective from $55 to $61 in a research report, according to a Mideast Times report.
Spinal Tech
Sonoma Orthopedic Products received FDA 510(k) clearance for the intramedullary FibuLock Nail.
Medtronic received FDA clearance for expanded indications of the VERTEX Reconstruction System.
According to a news report, K2M has received FDA clearance for its new MESA 2 Deformity Spinal System.
DePuy Synthes Spine receives FDA 510(k) clearance for its SYNAPSE Occipital-Cervical-Thoracic System
DePuy Synthes Spine received FDA 510(k) Clearance for its SYNAPSE Occipital-Cervical-Thoracis (OCT) System with posterior cervical screws, according to a press release.
Medtronic's board of directors approved a cash dividend of $0.305 per ordinary share.
Argus upped Zimmer's stock price target nearly $20, according to a WKRB News & Analysis report.
The platelet-rich plasma market is growing, according to a new Global Industry Analysis report.
The short interest in NuVasive shot up by 13.6 percent or 304,846 shares, according to a Candle Strips Bar & Graph Report.
LDR reported a rise of 64,902 shares or 5.8 percent in the short interest, according to a Markets Bureau report.
